Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00134056
Other study ID # CDR0000439434
Secondary ID S0421U10CA032102
Status Completed
Phase Phase 3
First received
Last updated
Start date August 2006
Est. completion date February 2016

Study information

Verified date October 2021
Source Southwest Oncology Group
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

RATIONALE: Drugs used in chemotherapy, such as docetaxel, prednisone, and atrasentan work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. It is not yet known whether docetaxel, prednisone, and atrasentan are more effective than docetaxel and prednisone in treating prostate cancer. PURPOSE: This randomized phase III trial is studying docetaxel, prednisone, and atrasentan to see how well they work compared to docetaxel and prednisone in treating patients with stage IV prostate cancer and bone metastases that did not respond to previous hormone therapy.


Description:

OBJECTIVES: Primary - Compare the survival and progression-free survival of patients with hormone-refractory stage IV prostate cancer and bone metastases treated with docetaxel and prednisone combined with either atrasentan vs placebo. Secondary - Compare pain progression of patients treated with these regimens. - Compare the qualitative and quantitative toxicity of these regimens in these patients. - Compare the quality of life, in terms of palliation of metastatic bone pain and improvement in functional status, of patients treated with these regimens. - Compare prostate-specific antigen (PSA) response rates in patients treated with these regimens. - Compare objective response in patients with measurable disease treated with these regimens. - Determine whether a 30% reduction in PSA and the slope of PSA from baseline to 3 months is a surrogate marker for survival in patients treated with these regimens. - Correlate PSA progression with clinical progression and death in patients treated with these regimens. OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients are stratified according to disease progression (measurable or non-measurable disease progression vs prostate-specific antigen progression only), use of bisphosphonates at study entry (yes vs no), worst pain, measured by the Brief Pain Inventory "pain" scale (< grade 4 vs ≥ grade 4), and extraskeletal metastases (yes vs no). Patients are randomized to 1 of 2 treatment arms. - Arm I: Patients receive docetaxel IV over 1 hour on day 1. Patients also receive oral atrasentan and oral prednisone once daily on days 1-21. Treatment repeats every 21 days for up to 12 courses. Patients with stable or responding disease after course 12 may register for continued oral atrasentan treatment for up to 52 weeks in the absence of disease progression* or unacceptable toxicity. - Arm II: Patients receive docetaxel and prednisone as in arm I. Patients also receive oral placebo once daily on days 1-21. Treatment repeat every 21 days for up to 12 courses. Patients with stable or responding disease after course 12 may register for continued oral placebo treatment for up to 52 weeks in the absence of disease progression* or unacceptable toxicity. NOTE: *Patients with PSA progression alone will be allowed to continue treatment Quality of life is assessed at baseline, before courses 4, 7, and 10, and then after completion of study treatment. After completion of study treatment, patients are followed every 3 months for 1 year and then every 6 months for up to 3 years from study entry. PROJECTED ACCRUAL: A total of 930 patients will be accrued for this study within 4 years.


Recruitment information / eligibility

Status Completed
Enrollment 1038
Est. completion date February 2016
Est. primary completion date February 2016
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility DISEASE CHARACTERISTICS: - Histologically confirmed adenocarcinoma of the prostate - Stage IV disease (any T, any N, M1b) - Evidence of bone metastases by bone scan or MRI - Measurable or nonmeasurable disease - Soft tissue disease that has been irradiated within the past 2 months is not assessable as measurable disease - Hormone-refractory disease despite androgen deprivation and antiandrogen withdrawal, as defined by 1 of the following criteria: - Prostate-specific antigen (PSA) progression, defined as 3 consecutive rising PSA levels* taken = 1 week apart - PSA = 5 ng/mL NOTE: *If the third confirmatory PSA level is < the second level, the patient is considered eligible provided a fourth PSA level is > the second level - Progression of measurable disease - Progression of nonmeasurable disease by bone scan - Must have undergone surgical or medical (e.g., luteinizing hormone-releasing hormone [LHRH] agonist [e.g., leuprolide or goserelin] or LHRH antagonist therapy) castration - Patients who have undergone medical castration must continue LHRH agonist or antagonist therapy during study treatment - Must have completed 12 courses of blinding protocol treatment (atrasentan/placebo) AND stopped docetaxel for any reason (including completion of 12 courses) other than progressive disease - No symptomatic pleural effusion - No third space fluid accumulation (e.g., ascites) - No prior or concurrent brain metastases - Patients with clinical evidence of brain metastases must have a negative brain CT scan or MRI within the past 8 weeks PATIENT CHARACTERISTICS: Age - 18 and over Performance status - Zubrod 0-3* NOTE: For a performance status of 3, the cause must be due to pain secondary to bone metastases Life expectancy - Not specified Hematopoietic - Not specified Hepatic - Not specified Renal - Not specified Other - Fertile patients must use effective contraception - Able to take oral medication without crushing, dissolving, or chewing tablets - No major infection - No other malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer or stage I or II cancer in complete remission - No symptomatic sensory neuropathy = grade 2 - No history of hypersensitivity reaction to docetaxel or other drugs formulated with polysorbate 80 - No other significant, active medical illness that would preclude study treatment or survival PRIOR CONCURRENT THERAPY: Biologic therapy - No more than 1 prior systemic vaccine or biologic therapy - At least 4 weeks since prior vaccine or biologic therapy and recovered - No concurrent biological response modifiers - No concurrent prophylactic colony-stimulating factors Chemotherapy - More than 2 years since prior adjuvant therapy with a single non-taxane-containing cytotoxic regimen - No prior cytotoxic chemotherapy for metastatic prostate cancer - No other concurrent chemotherapy Endocrine therapy - See Disease Characteristics - At least 6 weeks since prior bicalutamide or nilutamide AND has subsequent disease progression - At least 4 weeks since prior flutamide or ketoconazole AND has subsequent disease progression - Prior or concurrent megestrol for treatment of hot flashes allowed - No other concurrent corticosteroid or hormonal therapy unless continuing luteinizing hormone-releasing hormone treatment and/or bisphosphonate therapy Radiotherapy - See Disease Characteristics - Prior samarium allowed - At least 3 weeks since prior radiotherapy and recovered - No prior radiotherapy to = 30% of the bone marrow - No prior strontium - No concurrent radiotherapy Surgery - See Disease Characteristics - At least 3 weeks since prior surgery and recovered Other - More than 4 weeks since prior investigational drugs - Concurrent bisphosphonates allowed provided therapy is started prior to study entry, dose is maintained during the first 12 weeks of study treatment, and patient meets criteria for disease progression - No initiation of bisphosphonates during the first 12 weeks of study treatment - No concurrent herbal medications or food supplements (e.g., PC-SPES, saw palmetto, Hypericum perforatum [St. John's wort]) - Concurrent daily vitamins and calcium supplements allowed - At least 14 days since prior and no concurrent administration of any of the following: - Antibiotics (e.g., clarithromycin, erythromycin, troleandomycin, rifampin, rifabutin, and rifapentine) - Antifungals (e.g., itraconazole, ketoconazole, fluconazole [doses > 200 mg/day], and voriconazole) - Antidepressants (e.g., nefazodone and fluvoxamine) - Calcium channel blockers (e.g., verapamil, diltiazem) - Miscellaneous (e.g., amiodarone [no use within 6 months prior to study entry], grapefruit juice, bitter orange, or modafinil) - Anticonvulsants (e.g., phenytoin, carbamazepine, phenobarbital, and oxcarbazepine) - Antibiotics (e.g., rifampin, rifabutin, and rifapentine)

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
atrasentan hydrochloride
Given orally
docetaxel
Docetaxel given IV and prednisone given orally
prednisone
Docetaxel given IV and prednisone given orally
Other:
placebo
Given orally

Locations

Country Name City State
United States Kapiolani Medical Center at Pali Momi 'Aiea Hawaii
United States Oncology Services of Aberdeen Aberdeen South Dakota
United States Hickman Cancer Center at Bixby Medical Center Adrian Michigan
United States McDowell Cancer Center at Akron General Medical Center Akron Ohio
United States Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest Allentown Pennsylvania
United States Saint Anthony's Hospital at Saint Anthony's Health Center Alton Illinois
United States Harrington Cancer Center Amarillo Texas
United States American Fork Hospital American Fork Utah
United States McFarland Clinic, PC Ames Iowa
United States Alaska Regional Hospital Cancer Center Anchorage Alaska
United States AnMed Cancer Center Anderson South Carolina
United States CCOP - Michigan Cancer Research Consortium Ann Arbor Michigan
United States Saint Joseph Mercy Cancer Center Ann Arbor Michigan
United States University of Michigan Comprehensive Cancer Center Ann Arbor Michigan
United States Hospital District Sixth of Harper County Anthony Kansas
United States Langlade Memorial Hospital Antigo Wisconsin
United States Fox Valley Hematology and Oncology - East Grant Street Appleton Wisconsin
United States Randolph Hospital Asheboro North Carolina
United States Mission Hospitals - Memorial Campus Asheville North Carolina
United States Northeast Georgia Cancer Care, LLC - Medical Oncology Athens Georgia
United States CCOP - Atlanta Regional Atlanta Georgia
United States Northside Hospital Cancer Center Atlanta Georgia
United States Piedmont Hospital Atlanta Georgia
United States Saint Joseph's Hospital of Atlanta Atlanta Georgia
United States Auburn Regional Center for Cancer Care Auburn Washington
United States MBCCOP - Medical College of Georgia Cancer Center Augusta Georgia
United States Aurora Presbyterian Hospital Aurora Colorado
United States Rush-Copley Cancer Care Center Aurora Illinois
United States University of Colorado Cancer Center at UC Health Sciences Center Aurora Colorado
United States WellStar Cobb Hospital Austell Georgia
United States Greater Baltimore Medical Center Cancer Center Baltimore Maryland
United States Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland
United States Mary Bird Perkins Cancer Center - Baton Rouge Baton Rouge Louisiana
United States Pennington Cancer Center at Baton Rouge General Baton Rouge Louisiana
United States Battle Creek Health System Cancer Care Center Battle Creek Michigan
United States St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove Indiana
United States St. Joseph Cancer Center Bellingham Washington
United States MeritCare Bemidji Bemidji Minnesota
United States Green Mountain Oncology Group Bennington Vermont
United States Hematology Oncology Associates of the Quad Cities Bettendorf Iowa
United States Mecosta County Medical Center Big Rapids Michigan
United States Billings Clinic - Downtown Billings Montana
United States CCOP - Montana Cancer Consortium Billings Montana
United States Hematology-Oncology Centers of the Northern Rockies - Billings Billings Montana
United States Northern Rockies Radiation Oncology Center Billings Montana
United States St. Vincent Healthcare Cancer Care Services Billings Montana
United States Bismarck Cancer Center Bismarck North Dakota
United States Medcenter One Hospital Cancer Care Center Bismarck North Dakota
United States Mid Dakota Clinic, PC Bismarck North Dakota
United States St. Alexius Medical Center Cancer Center Bismarck North Dakota
United States Bloomington Hospital Regional Cancer Institute Bloomington Indiana
United States Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise Idaho
United States Boston University Cancer Research Center Boston Massachusetts
United States Boulder Community Hospital Boulder Colorado
United States Wood County Oncology Center Bowling Green Ohio
United States Bozeman Deaconess Cancer Center Bozeman Montana
United States Olympic Hematology and Oncology Bremerton Washington
United States Our Lady of Mercy Medical Center Comprehensive Cancer Center Bronx New York
United States Veterans Affairs Medical Center - Brooklyn Brooklyn New York
United States St. Joseph Regional Cancer Center Bryan Texas
United States Bryn Mawr Hospital Bryn Mawr Pennsylvania
United States Veterans Affairs Medical Center - Buffalo Buffalo New York
United States Alamance Cancer Center at Alamance Regional Medical Center Burlington North Carolina
United States Lahey Clinic Medical Center - Burlington Burlington Massachusetts
United States Fairview Ridges Hospital Burnsville Minnesota
United States St. James Healthcare Cancer Care Butte Montana
United States Saint Francis Medical Center Cape Girardeau Missouri
United States Rocky Mountain Oncology Casper Wyoming
United States East Bay Radiation Oncology Center Castro Valley California
United States Eden Medical Center Castro Valley California
United States Valley Medical Oncology Consultants - Castro Valley Castro Valley California
United States Sandra L. Maxwell Cancer Center Cedar City Utah
United States Iowa Blood and Cancer Care Cedar Rapids Iowa
United States Mercy Regional Cancer Center at Mercy Medical Center Cedar Rapids Iowa
United States St. Luke's Hospital Cedar Rapids Iowa
United States Providence Centralia Hospital Centralia Washington
United States Cancer Center of Kansas, PA - Chanute Chanute Kansas
United States Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina
United States West Virginia University Health Sciences Center - Charleston Charleston West Virginia
United States Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina
United States Saint Luke's Hospital Chesterfield Missouri
United States Creticos Cancer Center at Advocate Illinois Masonic Medical Center Chicago Illinois
United States Mount Sinai Hospital Medical Center Chicago Illinois
United States Resurrection Medical Center Chicago Illinois
United States University of Illinois Cancer Center Chicago Illinois
United States Marshfield Clinic - Chippewa Center Chippewa Falls Wisconsin
United States Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio
United States Veterans Affairs Medical Center - Cincinnati Cincinnati Ohio
United States MetroHealth Cancer Care Center at MetroHealth Medical Center Cleveland Ohio
United States Medical Oncology and Hematology Associates - West Des Moines Clive Iowa
United States North Coast Cancer Care - Clyde Clyde Ohio
United States Penrose Cancer Center at Penrose Hospital Colorado Springs Colorado
United States Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus Ohio
United States New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care Concord New Hampshire
United States Cookeville Regional Medical Center Cookeville Tennessee
United States Mercy and Unity Cancer Center at Mercy Hospital Coon Rapids Minnesota
United States Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital Cooperstown New York
United States Bay Area Hospital Coos Bay Oregon
United States Heartland Oncology and Hematology Council Bluffs Iowa
United States Medical City Dallas Hospital Dallas Texas
United States Veterans Affairs Medical Center - Dallas Dallas Texas
United States Praxair Cancer Center at Danbury Hospital Danbury Connecticut
United States Danville Regional Medical Center Danville Virginia
United States Geisinger Cancer Institute at Geisinger Health Danville Pennsylvania
United States Genesis Medical Center - West Campus Davenport Iowa
United States Genesis Regional Cancer Center at Genesis Medical Center Davenport Iowa
United States CCOP - Dayton Dayton Ohio
United States David L. Rike Cancer Center at Miami Valley Hospital Dayton Ohio
United States Good Samaritan Hospital Dayton Ohio
United States Grandview Hospital Dayton Ohio
United States Samaritan North Cancer Care Center Dayton Ohio
United States Veterans Affairs Medical Center - Dayton Dayton Ohio
United States Oakwood Cancer Center at Oakwood Hospital and Medical Center Dearborn Michigan
United States Charles B. Eberhart Cancer Center at DeKalb Medical Center Decatur Georgia
United States Decatur Memorial Hospital Cancer Care Institute Decatur Illinois
United States CCOP - Colorado Cancer Research Program Denver Colorado
United States Denver Health Medical Center Denver Colorado
United States Porter Adventist Hospital Denver Colorado
United States Presbyterian - St. Luke's Medical Center Denver Colorado
United States Rose Medical Center Denver Colorado
United States St. Anthony Central Hospital Denver Colorado
United States St. Joseph Hospital Denver Colorado
United States Veterans Affairs Medical Center - Denver Denver Colorado
United States CCOP - Iowa Oncology Research Association Des Moines Iowa
United States John Stoddard Cancer Center at Iowa Lutheran Hospital Des Moines Iowa
United States John Stoddard Cancer Center at Iowa Methodist Medical Center Des Moines Iowa
United States Medical Oncology and Hematology Associates at John Stoddard Cancer Center Des Moines Iowa
United States Medical Oncology and Hematology Associates at Mercy Cancer Center Des Moines Iowa
United States Mercy Cancer Center at Mercy Medical Center - Des Moines Des Moines Iowa
United States Mercy Capitol Hospital Des Moines Iowa
United States Josephine Ford Cancer Center at Henry Ford Hospital Detroit Michigan
United States Cancer Center of Kansas, PA - Dodge City Dodge City Kansas
United States CCOP - Duluth Duluth Minnesota
United States Duluth Clinic Cancer Center - Duluth Duluth Minnesota
United States Miller - Dwan Medical Center Duluth Minnesota
United States Veterans Affairs Medical Center - Durham Durham North Carolina
United States Veterans Affairs Medical Center - East Orange East Orange New Jersey
United States CCOP - Hematology-Oncology Associates of Central New York East Syracuse New York
United States Easton Regional Cancer Center at Easton Hospital Easton Pennsylvania
United States Shore Regional Cancer Center at Memorial Hospital - Easton Easton Maryland
United States Marshfield Clinic Cancer Care at Regional Cancer Center Eau Claire Wisconsin
United States Fairview Southdale Hospital Edina Minnesota
United States Shaw Regional Cancer Center Edwards Colorado
United States Cancer Center of Kansas, PA - El Dorado El Dorado Kansas
United States Sherman Hospital Elgin Illinois
United States Alexian Brothers Radiation Oncology Elk Grove Village Illinois
United States Elkhart General Hospital Elkhart Indiana
United States Vince Lombardi Cancer Center at Aurora Lakeland Medical Center - Elkhorn Elkhorn Wisconsin
United States Union Hospital Cancer Program at Union Hospital Elkton Maryland
United States Elmhurst Memorial Hospital Elmhurst Illinois
United States Falck Cancer Center at Arnot Ogden Medical Center Elmira New York
United States Hematology Oncology Center Elyria Ohio
United States Swedish Medical Center Englewood Colorado
United States Green Bay Oncology, Limited - Escanaba Escanaba Michigan
United States Evanston Hospital Evanston Illinois
United States Center for Cancer Care at Exeter Hospital Exeter New Hampshire
United States Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks Alaska
United States CCOP - MeritCare Hospital Fargo North Dakota
United States Dakota Cancer Institute at Dakota Clinic - South University Fargo North Dakota
United States MeritCare Broadway Fargo North Dakota
United States St. Francis Hospital Federal Way Washington
United States Fergus Falls Medical Group, PA Fergus Falls Minnesota
United States Blanchard Valley Medical Associates Findlay Ohio
United States Hunterdon Regional Cancer Center at Hunterdon Medical Center Flemington New Jersey
United States Genesys Hurley Cancer Institute Flint Michigan
United States Hurley Medical Center Flint Michigan
United States McLeod Regional Medical Center Florence South Carolina
United States Front Range Cancer Specialists Fort Collins Colorado
United States Poudre Valley Hospital Fort Collins Colorado
United States Broward General Medical Center Cancer Center Fort Lauderdale Florida
United States Brooke Army Medical Center Fort Sam Houston Texas
United States Cancer Center of Kansas - Fort Scott Fort Scott Kansas
United States Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith Arkansas
United States MetroWest Medical Center - Framingham Union Hospital Framingham Massachusetts
United States Middletown Regional Hospital Franklin Ohio
United States Oncology Alliance - Franklin Franklin Wisconsin
United States Fredericksburg Oncology, Incorporated Fredericksburg Virginia
United States Leonard C. Ferguson Cancer Center Freeport Illinois
United States Valley Medical Oncology Fremont California
United States Cancer Care Associates Fresno California
United States Mercy and Unity Cancer Center at Unity Hospital Fridley Minnesota
United States Glendale Memorial Hospital Comprehensive Cancer Center Glendale California
United States Oncology Alliance, SC - Milwaukee - East Glendale Wisconsin
United States Valley View Hospital Cancer Center Glenwood Springs Colorado
United States Riverside Middle Peninsula Cancer Center Gloucester Virginia
United States Southeastern Medical Oncology Center - Goldsboro Goldsboro North Carolina
United States Wayne Memorial Hospital, Incorporated Goldsboro North Carolina
United States Center for Cancer Care at Goshen General Hospital Goshen Indiana
United States Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center Grand Island Nebraska
United States St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center Grand Junction Colorado
United States Butterworth Hospital at Spectrum Health Grand Rapids Michigan
United States CCOP - Grand Rapids Grand Rapids Michigan
United States Lacks Cancer Center at Saint Mary's Health Care Grand Rapids Michigan
United States Big Sky Oncology Great Falls Montana
United States Frontier Cancer Center Great Falls Montana
United States Great Falls Clinic - Main Facility Great Falls Montana
United States Sletten Cancer Institute at Benefis Healthcare Great Falls Montana
United States North Colorado Medical Center Greeley Colorado
United States Green Bay Oncology, Limited at St. Mary's Hospital Green Bay Wisconsin
United States Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center Green Bay Wisconsin
United States St. Mary's Hospital Medical Center - Green Bay Green Bay Wisconsin
United States St. Vincent Hospital Regional Cancer Center Green Bay Wisconsin
United States Moses Cone Regional Cancer Center at Wesley Long Community Hospital Greensboro North Carolina
United States Wayne Hospital Greenville Ohio
United States Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods Michigan
United States Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford Connecticut
United States Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey Illinois
United States Northern Montana Hospital Havre Montana
United States Geisinger Hazleton Cancer Center Hazleton Pennsylvania
United States St. Peter's Hospital Helena Montana
United States Veterans Affairs Medical Center - Hines Hines Illinois
United States Memorial Cancer Institute at Memorial Regional Hospital Hollywood Florida
United States Cancer Research Center of Hawaii Honolulu Hawaii
United States Hawaii Medical Center - East Honolulu Hawaii
United States Kapiolani Medical Center for Women and Children Honolulu Hawaii
United States OnCare Hawaii, Incorporated - Kuakini Honolulu Hawaii
United States OnCare Hawaii, Incorporated - Lusitana Honolulu Hawaii
United States Queen's Cancer Institute at Queen's Medical Center Honolulu Hawaii
United States Straub Clinic and Hospital, Incorporated Honolulu Hawaii
United States Tripler Army Medical Center Honolulu Hawaii
United States New Hampshire Oncology - Hematology, PA - Hooksett Hooksett New Hampshire
United States Baylor University Medical Center - Houston Houston Texas
United States Ben Taub General Hospital Houston Texas
United States Methodist Hospital Houston Texas
United States St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital Houston Texas
United States Veterans Affairs Medical Center - Houston Houston Texas
United States Cancer Center of Kansas-Independence Independence Kansas
United States Independence Regional Health Center Independence Missouri
United States Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana
United States Veterans Affairs Medical Center - Indianapolis Indianapolis Indiana
United States William N. Wishard Memorial Hospital Indianapolis Indiana
United States Dickinson County Healthcare System Iron Mountain Michigan
United States Foote Memorial Hospital Jackson Michigan
United States University of Mississippi Cancer Clinic Jackson Mississippi
United States Veterans Affairs Medical Center - Jackson Jackson Mississippi
United States UW Cancer Center Johnson Creek Johnson Creek Wisconsin
United States Joliet Oncology-Hematology Associates, Limited - West Joliet Illinois
United States Freeman Cancer Institute at Freeman Health System Joplin Missouri
United States Borgess Medical Center Kalamazoo Michigan
United States Bronson Methodist Hospital Kalamazoo Michigan
United States West Michigan Cancer Center Kalamazoo Michigan
United States Glacier Oncology, PLLC Kalispell Montana
United States Kalispell Medical Oncology at KRMC Kalispell Montana
United States Kalispell Regional Medical Center Kalispell Montana
United States Provena St. Mary's Regional Cancer Center - Kankakee Kankakee Illinois
United States CCOP - Kansas City Kansas City Missouri
United States Heartland Hematology Oncology Associates, Incorporated Kansas City Missouri
United States Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Kansas
United States North Kansas City Hospital Kansas City Missouri
United States Parvin Radiation Oncology Kansas City Missouri
United States Research Medical Center Kansas City Missouri
United States Saint Luke's Cancer Institute at Saint Luke's Hospital Kansas City Missouri
United States St. Joseph Medical Center Kansas City Missouri
United States Truman Medical Center - Hospital Hill Kansas City Missouri
United States Veterans Affairs Medical Center - Kansas City Kansas City Missouri
United States Good Samaritan Cancer Center at Good Samaritan Hospital Kearney Nebraska
United States Columbia Basin Hematology Kennewick Washington
United States Oncology Alliance - Kenosha South Kenosha Wisconsin
United States Charles F. Kettering Memorial Hospital Kettering Ohio
United States Cancer Center of Kansas, PA - Kingman Kingman Kansas
United States Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center Kingsport Tennessee
United States Kinston Medical Specialists Kinston North Carolina
United States Cascade Cancer Center at Evergreen Hospital Medical Center Kirkland Washington
United States Thompson Cancer Survival Center Knoxville Tennessee
United States Howard Community Hospital Kokomo Indiana
United States Gundersen Lutheran Center for Cancer and Blood La Crosse Wisconsin
United States La Grange Memorial Hospital La Grange Illinois
United States Rebecca and John Moores UCSD Cancer Center La Jolla California
United States Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte Indiana
United States Wilford Hall Medical Center Lackland Air Force Base Texas
United States Lakes Region General Hospital Laconia New Hampshire
United States Clarian Arnett Cancer Care Lafayette Indiana
United States Haematology-Oncology Associates of Ohio and Michigan, PC Lambertville Michigan
United States Sparrow Regional Cancer Center Lansing Michigan
United States CCOP - Nevada Cancer Research Foundation Las Vegas Nevada
United States Nevada Cancer Institute Las Vegas Nevada
United States University Medical Center of Southern Nevada Las Vegas Nevada
United States Lawrence Memorial Hospital Lawrence Kansas
United States Gwinnett Medical Center Lawrenceville Georgia
United States Cleo Craig Cancer Research Clinic Lawton Oklahoma
United States Saint Luke's East - Lee's Summit Lee's Summit Missouri
United States Cancer Centers of Central Florida, PA Leesburg Florida
United States Southwest Medical Center Liberal Kansas
United States Liberty Hospital Liberty Missouri
United States St. Rita's Medical Center Lima Ohio
United States St. Mary Mercy Hospital Livonia Michigan
United States Logan Regional Hospital Logan Utah
United States Sky Ridge Medical Center Lone Tree Colorado
United States Hope Cancer Care Center at Longmont United Hospital Longmont Colorado
United States USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California
United States James Graham Brown Cancer Center at University of Louisville Louisville Kentucky
United States McKee Medical Center Loveland Colorado
United States UMC Southwest Cancer and Research Center Lubbock Texas
United States Lynchburg Hematology-Oncology Clinic Lynchburg Virginia
United States University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison Wisconsin
United States Manchester Memorial Hospital Manchester Connecticut
United States Holy Family Memorial Medical Center Cancer Care Center Manitowoc Wisconsin
United States Minnesota Oncology Hematology, PA - Maplewood Maplewood Minnesota
United States Kennestone Cancer Center at Wellstar Kennestone Hospital Marietta Georgia
United States Bay Area Cancer Care Center at Bay Area Medical Center Marinette Wisconsin
United States Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton Marlton New Jersey
United States Upper Michigan Cancer Center at Marquette General Hospital Marquette Michigan
United States Marshfield Clinic - Marshfield Center Marshfield Wisconsin
United States Saint Joseph's Hospital Marshfield Wisconsin
United States Contra Costa Regional Medical Center Martinez California
United States Tibotec Therapeutics - Division of Ortho Biotech Products, LP Marysville California
United States Northwest Ohio Oncology Center Maumee Ohio
United States St. Luke's Hospital Maumee Ohio
United States Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood Illinois
United States University of Tennessee Cancer Institute - Memphis Memphis Tennessee
United States Veterans Affairs Medical Center - Memphis Memphis Tennessee
United States University of Miami Sylvester Comprehensive Cancer Center - Miami Miami Florida
United States Saint Anthony Memorial Health Centers Michigan City Indiana
United States Middlesex Hospital Cancer Center Middletown Connecticut
United States Froedtert Hospital and Medical College of Wisconsin Milwaukee Wisconsin
United States Medical College of Wisconsin Cancer Center Milwaukee Wisconsin
United States Medical Consultants, Limited Milwaukee Wisconsin
United States Oncology Alliance, SC - Milwaukee - South Milwaukee Wisconsin
United States Providence Milwaukie Hospital Milwaukie Oregon
United States Veterans Affairs Medical Center - Minneapolis Minneapolis Minnesota
United States Virginia Piper Cancer Institute at Abbott - Northwestern Hospital Minneapolis Minnesota
United States Marshfield Clinic - Lakeland Center Minocqua Wisconsin
United States Trinity CancerCare Center Minot North Dakota
United States Community Medical Center Missoula Montana
United States Guardian Oncology and Center for Wellness Missoula Montana
United States Montana Cancer Center at St. Patrick Hospital and Health Sciences Center Missoula Montana
United States Montana Cancer Specialists at Montana Cancer Center Missoula Montana
United States Providence Cancer Center at Providence Hospital Mobile Alabama
United States Community Cancer Center of Monroe Monroe Michigan
United States Mercy Memorial Hospital - Monroe Monroe Michigan
United States Community Hospital of the Monterey Peninsula Comprehensive Cancer Center Monterey California
United States Montrose Memorial Hospital Cancer Center Montrose Colorado
United States Clemens Regional Medical Center Mount Clemens Michigan
United States Northern Westchester Hospital Mount Kisco New York
United States Good Samaritan Regional Health Center Mount Vernon Illinois
United States Camino Medical Group - Treatment Center Mountain View California
United States El Camino Hospital Cancer Center Mountain View California
United States Medical Consultants, PC at Ball Memorial Cancer Center Muncie Indiana
United States Community Hospital Munster Indiana
United States Jon and Karen Huntsman Cancer Center at Intermountain Medical Center Murray Utah
United States Mercy General Health Partners Muskegon Michigan
United States Edward Hospital Cancer Center Naperville Illinois
United States Hematology Oncology Consultants - Naperville Naperville Illinois
United States Jersey Shore Cancer Center at Jersey Shore University Medical Center Neptune New Jersey
United States MBCCOP - LSU Health Sciences Center New Orleans Louisiana
United States Medical Center of Louisiana - New Orleans New Orleans Louisiana
United States Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York New York
United States New York Weill Cornell Cancer Center at Cornell University New York New York
United States CCOP - Christiana Care Health Services Newark Delaware
United States Peninsula Cancer Institute - Newport News Office Newport News Virginia
United States Cancer Center of Kansas, PA - Newton Newton Kansas
United States Callahan Cancer Center at Great Plains Regional Medical Center North Platte Nebraska
United States Southwest Virginia Regional Cancer Center at Wellmonth Health Norton Virginia
United States Fisher-Titus Medical Center Norwalk Ohio
United States Alta Bates Summit Medical Center - Summit Campus Oakland California
United States Bay Area Breast Surgeons, Incorporated Oakland California
United States CCOP - Bay Area Tumor Institute Oakland California
United States Highland General Hospital Oakland California
United States Larry G Strieff MD Medical Corporation Oakland California
United States Tom K Lee, Incorporated Oakland California
United States Green Bay Oncology, Limited - Oconto Falls Oconto Falls Wisconsin
United States Val and Ann Browning Cancer Center at McKay-Dee Hospital Center Ogden Utah
United States Providence St. Peter Hospital Regional Cancer Center Olympia Washington
United States UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha Nebraska
United States Integrated Community Oncology Network - Orange Park Orange Park Florida
United States St. Charles Mercy Hospital Oregon Ohio
United States Toledo Clinic - Oregon Oregon Ohio
United States Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando Florida
United States McCreery Cancer Center at Ottumwa Regional Ottumwa Iowa
United States Menorah Medical Center Overland Park Kansas
United States Saint Luke's Hospital - South Overland Park Kansas
United States Desert Regional Medical Center Comprehensive Cancer Center Palm Springs California
United States Palo Alto Medical Foundation Palo Alto California
United States Cancer Center of Paoli Memorial Hospital Paoli Pennsylvania
United States Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital Parkersburg West Virginia
United States Cancer Center of Kansas, PA - Parsons Parsons Kansas
United States Regional Cancer Center at Singing River Hospital Pascagoula Mississippi
United States Sacred Heart Cancer Center at Sacred Heart Hospital Pensacola Florida
United States West Florida Cancer Institute at West Florida Hospital - Pensacola Pensacola Florida
United States Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania
United States PCR Oncology Pismo Beach California
United States Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh Pennsylvania
United States Valley Care Medical Center Pleasanton California
United States Valley Medical Oncology Consultants - Pleasanton Pleasanton California
United States St. Joseph Mercy Oakland Pontiac Michigan
United States Mercy Regional Cancer Center at Mercy Hospital Port Huron Michigan
United States Adventist Medical Center Portland Oregon
United States CCOP - Columbia River Oncology Program Portland Oregon
United States Kaiser Permanente Health Care - Portland Portland Oregon
United States Providence Cancer Center at Providence Portland Medical Center Portland Oregon
United States Providence St. Vincent Medical Center Portland Oregon
United States Harrison Poulsbo Hematology and Onocology Poulsbo Washington
United States Cancer Center of Kansas, PA - Pratt Pratt Kansas
United States Utah Valley Regional Medical Center - Provo Provo Utah
United States St. Mary - Corwin Regional Medical Center Pueblo Colorado
United States Good Samaritan Cancer Center Puyallup Washington
United States Lucy Curci Cancer Center at Eisenhower Memorial Hospital and Medical Center Rancho Mirage California
United States Rapid City Regional Hospital Rapid City South Dakota
United States Annie Penn Cancer Center Reidsville North Carolina
United States Renown Institute for Cancer at Renown Regional Medical Center Reno Nevada
United States Valley Medical Center Renton Washington
United States Ministry Medical Group at Saint Mary's Hospital Rhinelander Wisconsin
United States Marshfield Clinic - Indianhead Center Rice Lake Wisconsin
United States Reid Hospital & Health Care Services Richmond Indiana
United States Veterans Affairs Medical Center - Richmond Richmond Virginia
United States Virginia Commonwealth University Massey Cancer Center Richmond Virginia
United States Valley Hospital - Ridgewood Ridgewood New Jersey
United States Southern Regional Medical Center Riverdale Georgia
United States Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center Robbinsdale Minnesota
United States Interlakes Oncology/Hematology PC Rochester New York
United States James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester New York
United States Mayo Clinic Cancer Center Rochester Minnesota
United States Swedish-American Regional Cancer Center Rockford Illinois
United States Harbin Clinic Cancer Center - Medical Oncology Rome Georgia
United States Rutherford Hospital Rutherfordton North Carolina
United States Mercy General Hospital Sacramento California
United States University of California Davis Cancer Center Sacramento California
United States Seton Cancer Institute at Saint Mary's - Saginaw Saginaw Michigan
United States CentraCare Clinic - River Campus Saint Cloud Minnesota
United States Coborn Cancer Center Saint Cloud Minnesota
United States Dixie Regional Medical Center - East Campus Saint George Utah
United States Heartland Regional Medical Center Saint Joseph Missouri
United States Lakeland Regional Cancer Care Center - St. Joseph Saint Joseph Michigan
United States Arch Medical Services, Incorporated at Center for Cancer Care and Research Saint Louis Missouri
United States CCOP - St. Louis-Cape Girardeau Saint Louis Missouri
United States David C. Pratt Cancer Center at St. John's Mercy Saint Louis Missouri
United States Midwest Hematology Oncology Group, Incorporated Saint Louis Missouri
United States Missouri Baptist Cancer Center Saint Louis Missouri
United States CCOP - Metro-Minnesota Saint Louis Park Minnesota
United States Park Nicollet Cancer Center Saint Louis Park Minnesota
United States United Hospital Saint Paul Minnesota
United States Cancer Center of Kansas, PA - Salina Salina Kansas
United States Tammy Walker Cancer Center at Salina Regional Health Center Salina Kansas
United States Salinas Valley Memorial Hospital Salinas California
United States Huntsman Cancer Institute at University of Utah Salt Lake City Utah
United States LDS Hospital Salt Lake City Utah
United States Utah Cancer Specialists at UCS Cancer Center Salt Lake City Utah
United States Cancer Therapy and Research Center San Antonio Texas
United States University Hospital - San Antonio San Antonio Texas
United States University of Texas Health Science Center at San Antonio San Antonio Texas
United States Veterans Affairs Medical Center - San Antonio (Murphy) San Antonio Texas
United States Doctors Medical Center - San Pablo Campus San Pablo California
United States North Coast Cancer Care, Incorporated Sandusky Ohio
United States Guthrie Cancer Center at Guthrie Clinic Sayre Sayre Pennsylvania
United States Mayo Clinic Scottsdale Scottsdale Arizona
United States Hematology and Oncology Associates of Northeastern Pennsylvania Scranton Pennsylvania
United States CCOP - Virginia Mason Research Center Seattle Washington
United States Fred Hutchinson Cancer Research Center Seattle Washington
United States Group Health Central Hospital Seattle Washington
United States Harborview Medical Center Seattle Washington
United States Minor and James Medical, PLLC Seattle Washington
United States Pacific Medical Center Seattle Washington
United States Polyclinic First Hill Seattle Washington
United States Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle Washington
United States University Cancer Center at University of Washington Medical Center Seattle Washington
United States St. Francis Cancer Center at St. Francis Medical Center Shakopee Minnesota
United States Shawnee Mission Medical Center Shawnee Mission Kansas
United States Welch Cancer Center at Sheridan Memorial Hospital Sheridan Wyoming
United States Feist-Weiller Cancer Center at Louisiana State University Health Sciences Shreveport Louisiana
United States Highland Clinic Shreveport Louisiana
United States Mercy Medical Center - Sioux City Sioux City Iowa
United States Siouxland Hematology-Oncology Associates, LLP Sioux City Iowa
United States St. Luke's Regional Medical Center Sioux City Iowa
United States Avera Cancer Institute Sioux Falls South Dakota
United States Medical X-Ray Center, PC Sioux Falls South Dakota
United States Sanford Cancer Center at Sanford USD Medical Center Sioux Falls South Dakota
United States Somerset Medical Center Somerville New Jersey
United States CCOP - Northern Indiana CR Consortium South Bend Indiana
United States Memorial Hospital of South Bend South Bend Indiana
United States Saint Joseph Regional Medical Center South Bend Indiana
United States South Bend Clinic South Bend Indiana
United States Providence Cancer Institute at Providence Hospital - Southfield Campus Southfield Michigan
United States Frederick R. and Betty M. Smith Cancer Treatment Center Sparta New Jersey
United States CCOP - Upstate Carolina Spartanburg South Carolina
United States Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg South Carolina
United States Cancer Care Northwest - Spokane South Spokane Washington
United States Evergreen Hematology and Oncology, PS Spokane Washington
United States Rockwood Clinic Cancer Treatment Center Spokane Washington
United States Baystate Regional Cancer Program at D'Amour Center for Cancer Care Springfield Massachusetts
United States Regional Cancer Center at Memorial Medical Center Springfield Illinois
United States Geisinger Medical Group - Scenery Park State College Pennsylvania
United States Mount Nittany Medical Center State College Pennsylvania
United States Nalitt Cancer Institute at Staten Island University Hospital Staten Island New York
United States Saint Michael's Hospital Cancer Center Stevens Point Wisconsin
United States Stony Brook University Cancer Center Stony Brook New York
United States Green Bay Oncology, Limited - Sturgeon Bay Sturgeon Bay Wisconsin
United States Flower Hospital Cancer Center Sylvania Ohio
United States SUNY Upstate Medical University Hospital Syracuse New York
United States Veterans Affairs Medical Center - Syracuse Syracuse New York
United States Allenmore Hospital Tacoma Washington
United States CCOP - Northwest Tacoma Washington
United States Franciscan Cancer Center at St. Joseph Medical Center Tacoma Washington
United States MultiCare Regional Cancer Center at Tacoma General Hospital Tacoma Washington
United States St. Clare Hospital Tacoma Washington
United States CCOP - Scott and White Hospital Temple Texas
United States North Suburban Medical Center Thornton Colorado
United States Mercy Hospital of Tiffin Tiffin Ohio
United States Space Coast Medical Associates Titusville Florida
United States CCOP - Toledo Community Hospital Toledo Ohio
United States Medical University of Ohio Cancer Center Toledo Ohio
United States St. Anne Mercy Hospital Toledo Ohio
United States St. Vincent Mercy Medical Center Toledo Ohio
United States Toledo Clinic, Incorporated - Main Clinic Toledo Ohio
United States Toledo Hospital Toledo Ohio
United States Cotton-O'Neil Cancer Center Topeka Kansas
United States St. Francis Comprehensive Cancer Center Topeka Kansas
United States Connecticut Oncology & Hematology - Torrington Torrington Connecticut
United States Munson Medical Center Traverse City Michigan
United States UVMC Cancer Care Center at Upper Valley Medical Center Troy Ohio
United States Tahoe Forest Cancer Center Truckee California
United States Arizona Cancer Center at University of Arizona Health Sciences Center Tucson Arizona
United States Carle Cancer Center at Carle Foundation Hospital Urbana Illinois
United States CCOP - Carle Cancer Center Urbana Illinois
United States Southwest Washington Medical Center Cancer Center Vancouver Washington
United States Cancer Institute of New Jersey at Cooper - Voorhees Voorhees New Jersey
United States Fox Chase Virtua Health Cancer Program at Virtua West Jersey Voorhees New Jersey
United States Ridgeview Medical Center Waconia Minnesota
United States Maui Memorial Medical Center Wailuku Hawaii
United States Pacific Cancer Institute - Maui Wailuku Hawaii
United States St. John Macomb Hospital Warren Michigan
United States Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington District of Columbia
United States Marion L. Shepard Cancer Center at Beaufort County Hospital Washington North Carolina
United States Sibley Memorial Hospital Washington District of Columbia
United States Veterans Affairs Medical Center - Washington, DC Washington District of Columbia
United States Cedar Valley Medical Specialists, PC - West Ridgeway Avenue Waterloo Iowa
United States Covenant Cancer Treatment Center Waterloo Iowa
United States Marshfield Clinic - Wausau Center Wausau Wisconsin
United States University of Wisconcin Cancer Center at Aspirus Wausau Hospital Wausau Wisconsin
United States Fulton County Health Center Wauseon Ohio
United States Oncology Alliance, SC - Milwaukee - West Wauwatosa Wisconsin
United States Cancer Center of Kansas, PA - Wellington Wellington Kansas
United States Wenatchee Valley Medical Center Wenatchee Washington
United States Marshfield Clinic - Weston Center Weston Wisconsin
United States Exempla Lutheran Medical Center Wheat Ridge Colorado
United States Schiffler Cancer Center at Wheeling Hospital Wheeling West Virginia
United States Associates in Womens Health, PA - North Review Wichita Kansas
United States Cancer Center of Kansas, PA - Medical Arts Tower Wichita Kansas
United States Cancer Center of Kansas, PA - Wichita Wichita Kansas
United States CCOP - Wichita Wichita Kansas
United States Via Christi Cancer Center at Via Christi Regional Medical Center Wichita Kansas
United States Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center Wilkes-Barre Pennsylvania
United States Peninsula Cancer Institute - Williamsburg Office Williamsburg Virginia
United States Willmar Cancer Center at Rice Memorial Hospital Willmar Minnesota
United States Clinton Memorial Hospital Wilmington Ohio
United States Cancer Center of Kansas, PA - Winfield Winfield Kansas
United States Central Dupage Cancer Center Winfield Illinois
United States Marshfield Clinic - Wisconsin Rapids Center Wisconsin Rapids Wisconsin
United States Riverview UW Cancer Center at Riverview Hospital Wisconsin Rapids Wisconsin
United States Minnesota Oncology Hematology, PA - Woodbury Woodbury Minnesota
United States United States Air Force Medical Center - Wright-Patterson Wright-Patterson Air Force Base Ohio
United States CCOP - Main Line Health Wynnewood Pennsylvania
United States Lankenau Cancer Center at Lankenau Hospital Wynnewood Pennsylvania
United States Metro Health Hospital Wyoming Michigan
United States Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia Ohio

Sponsors (2)

Lead Sponsor Collaborator
Southwest Oncology Group National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

References & Publications (5)

Goldkorn A, Ely B, Quinn DI, et al.: Results of telomerase activity measurements from live circulating tumor cells captured on a slot microfilter in a phase III SWOG-coordinated prostate cancer trial (S0421). [Abstract] J Clin Oncol 30 (Suppl 15): A-4663,

Goldkorn A, Xu T, Lu B, et al.: Circulating tumor cell capture and analysis in a multicenter SWOG-coordinated prostate cancer trial. [Abstract] J Clin Oncol 28 (Suppl 15): A-TPS342, 2010.

Lara P, Ely B, Quinn DI, et al.: SWOG 0421: prognostic and predictive value of bone metabolism biomarkers (BMB) in castration resistant prostate cancer (CRPC) patients (pts) with skeletal metastases treated with docetaxel (DOC) with or without atrasentan

Quinn DI, Tangen CM, Hussain M, et al.: SWOG S0421: phase III study of docetaxel (D) and atrasentan (A) versus docetaxel and placebo (P) for men with advanced castrate resistant prostate cancer (CRPC). [Abstract] J Clin Oncol 30 (Suppl 15): A-4511, 2012.

Vogelzang NJ, Ely B, Fink LM, et al.: Circulating tumor cell counts (CTC) as prognostic of overall survival (OS) in SWOG S0421-docetaxel with or without atrasentan for metastatic castration resistant prostate cancer (mCRPC). [Abstract] J Clin Oncol 30 (Su

Outcome

Type Measure Description Time frame Safety issue
Other Compare Elements of Quality of Life Between Treatment Arms: Pain Palliation Response, as Measured by the Brief Pain Inventory (BPI) Pain palliation is the proportion of patients showing a two-point reduction in the Worst Pain score (WPS) maintained for two consecutive assessments with no increase in analgesic use. Increase in analgesic use is defined as an increase in Analgesic code Level to 2 (weak opioid) or 3 (strong opioid). Patients will be classified as pain palliated or not palliated. Patients with a WPS of "0" will be defined as "stable" if their WPS remains "0" for Weeks 7 and 10 with no increase in analgesic use, but they will not be categorized as responders. Pain palliation response is measured by BPI short form that has the following: yes/no question about pain today; 4 pain rating questions (worst pain, least pain, average pain, and current pain); pain medications and pain relief; 7 items addressing effect of pain on functioning. For patients who continue to receive treatment beyond 12 treatment cycles, the Worst Pain item is measured by Pain Medication Log and Pain Assessment up to 18 months study period
Other Number of Patients With a Change in Functional Status Functional status will be measured with the Functional Assessment of Cancer Therapy-Prostate (FACT-P) Trial Outcome Index. The FACT-P also addresses four general domains of QOL (physical, functional, emotional, and social well-being subscales) as well as symptom concerns associated with prostate cancer and its treatment. up to 18 months study period
Primary Compare Survival Between a Control or Standard Therapy Arm of Docetaxel + Placebo + Prednisone With Docetaxel + Atrasentan + Prednisone in Patients With Hormone Refractory Prostate Cancer. Measured from date of registration to date of death due to any cause. Patient last known to be alive are censored at date of last contact. Up to 7 years after study opens
Primary Compare Progression-free Survival Between a Control or Standard Therapy Arm of Docetaxel + Placebo + Prednisone With Docetaxel + Atrasentan + Prednisone in Patients With Hormone Refractory Prostate Cancer. Measured from date of registration to date of first observation of progressive disease, or death due to any cause. Patients without progression are censored at date of last contact. Disease progression is defined by confirmed bone disease progression, soft tissue or pain progression. Up to 7 years after study opens
Secondary Compare Pain Progression Between the Two Study Arms. Pain progression is defined as patients reporting an increase of at least two Worst Pain points, maintained for at least two consecutive assessments, increase to Level 3 (strong opioid) on the Pain Medication Log Analgesic Code for patients receiving Level 2 (weak opioid) analgesics at randomization, or an increase to Level 2 or 3 analgesics for patients receiving Level 0 or 1 analgesics at randomization. Up to 52 weeks
Secondary Compare Qualitative and Quantitative Toxicity Between the Two Study Arms Only adverse events that are possibly, probably or definitely related to study drug are reported. Assessed every 3 weeks up to 52 weeks
Secondary Compare Prostate Specific Antigen (PSA) Response Rates Between the Experimental Arm and the Standard Arm. PSA Partial Response: Greater than or equal to 50% reduction in baseline PSA. There must be no evidence of soft tissue progression, or confirmed none disease progression, or pain progression. Up to 7 years after study opens
Secondary Compare Objective Responses Between the Two Treatment Groups in Patients With Measurable Disease as Defined by RECIST Criteria. Complete Response (CR): Complete disappearance of all measurable and non-measurable disease. No new lesions. No disease related symptoms. Normalization of markers and other abnormal lab values. PSA = .2 ng/ml. Partial Response (PR): Applies only to patients with at least one measurable lesion. Greater than or equal to 30% decrease under baseline of the sum of longest diameters of all target measurable lesions. No unequivocal progression of non-measurable disease. No new lesions. Up to 52 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A